COVID-19: Another coronavirus vaccine set to enter production within weeks - and UK has 60m doses ordered

Production of the coronavirus vaccine developed by French firm Sanofi and GlaxoSmithKline (GSK) will begin within weeks, the firms have said. The two companies are currently in Phase 3 of their trials, which will see 35,000 adult volunteers receive their coronavirus jab across the US, Asia, Africa, and Latin America. They will test for effectiveness against the original form of COVID-19 that swept across the world after emerging in Wuhan, China, in late 2019 - and also the variant first detected in South Africa. 'Manufacturing will begin in the coming weeks to enable rapid access to the vaccine should it be approved,' a joint statement from Sanofi and GSK said. The Sanofi-GSK vaccine could be given the green light by drugs regulators in the final three months of this year if the Phase 3 trials are successful.